Investment Analysts’ Recent Ratings Updates for CareDx (CDNA)
CareDx (NASDAQ: CDNA) was the recipient of a ratings changes during the seven days:
- CareDx is now covered by analysts at Piper Jaffray. They set an “overweight” rating and a $13.00 price target on the stock.
- CareDx is now covered by analysts at Raymond James. They set an “outperform” rating and a $12.50 price target on the stock.
- CareDx is now covered by analysts at Mizuho. They set a “buy” rating and a $15.00 price target on the stock.
- CareDx is now covered by analysts at Leerink Swann. They set an “outperform” rating and a $13.00 price target on the stock.
Shares of CareDx Inc (NASDAQ:CDNA) traded down 0.12% during mid-day trading on Thursday, hitting $10.1776. 1,630 shares of the company’s stock traded hands. CareDx Inc has a one year low of $8.49 and a one year high of $10.88. The stock’s 50-day moving average is $9.8 and its 200-day moving average is $9.8. The company’s market cap is $117.8 million.
CareDx, Inc is a commercial stage company that develops markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a patient’s lifetime.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.